UnderRepresentation of Women in Clinical Trials CVD in Women Women s CV Risk is Often Misunderstood or Misdiagnosed Gender Disparities in Screening Diagnosis and Treatment of Dyslipidemia ID: 698862
Download Presentation The PPT/PDF document "Tailoring Statin Therapy in Women" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Tailoring Statin Therapy in WomenSlide2Slide3
Under-Representation of Women
in Clinical TrialsSlide4
CVD in WomenSlide5
Women
’
s CV Risk is Often Misunderstood or MisdiagnosedSlide6
Gender Disparities in Screening, Diagnosis, and Treatment of DyslipidemiaSlide7
Statin Adherence Rates (USAGE Survey)Slide8
Patient Education and
Shared Decision MakingSlide9
Novel Risk Factors in WomenSlide10
Gender Disparities in Heart Attack SymptomsSlide11
Effects of Hormonal Contraceptives
on Lipid LevelsSlide12
Statin Metabolism in WomenSlide13
ACC/AHA/NHLBI Clinical Advisory
Risk Factors for Statin-MyopathySlide14
Hormonal Contraceptives: Androgenic EffectSlide15
Patient Case
Familial Hypercholesterolemia Slide16
Patient Case
Potential Problems and SolutionsSlide17
Know Your Patient
Young College StudentSlide18
Educating Women of Childbearing Age
Statin Adverse Fetal EffectsSlide19
Women and Menopause Slide20
Older Age Equals Increased Risk
for CVDSlide21
Considerations in the ElderlySlide22
Cardiac Care and Statin Therapy in WomenSlide23
Lifestyle Modifications for WomenSlide24
SummarySlide25
AbbreviationsSlide26
Abbreviations (cont)